Sandoz has obtained commercial rights in Germany, the Netherlands and the UK to
Sandoz Strikes Shionogi Partnership as Part of Pain Play
By securing commercial rights to Shionogi’s Rizmoic drug for opioid-induced constipation, Sandoz is seeking to broaden its European pain treatments portfolio.
